Video Experimental Relacionado
Updated: May 5, 2026
11:17
Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
15.4K
Hirudina recombinante en la práctica clínica: el foco está en la lepirudina
1Institute for Immunology and Transfusion Medicine, Ernst-Moritz-Arndt-University Greifswald, Greifswald, Germany.
Circulation
|March 14, 2001
Resumen
La lepirudina, una hirudina recombinante, está aprobada para la trombocitopenia inducida por heparina (HIT). Pruebas recientes sugieren su eficacia en la angina inestable, ampliando sus aplicaciones clínicas. Esta revisión incluye la lepirudina.
Área de la Ciencia:
- Farmacología y medicina clínica.
- La trombosis y la terapia anticoagulante.
Sus antecedentes:
- Las hirudinas recombinantes se han explorado para uso clínico en la última década.
- La lepirudina es la primera hirudina aprobada, principalmente para el tratamiento de la trombocitopenia inducida por heparina (HIT).
Objetivo del estudio:
- Revisar la farmacología y las aplicaciones clínicas de la lepirudina.
- Centrarse en el papel establecido de la lepirudina en el HIT y su uso emergente en la angina inestable.
Principales métodos:
- Revisión de la literatura de ensayos clínicos y datos farmacológicos sobre la lepirudina.
- Análisis de la eficacia y seguridad de la lepirudina en varias indicaciones.
Principales resultados:
- La lepirudina es un tratamiento establecido para la trombocitopenia inducida por heparina (HIT).
- Los ensayos clínicos indican nuevas indicaciones potenciales para la lepirudina, especialmente en la angina inestable.
- También se discute el uso en síndromes coronarios agudos e indicaciones raras como la circulación extracorpórea.
Conclusiones:
- La lepirudina es un valioso anticoagulante con un papel comprobado en HIT.
- Se necesitan más investigaciones y datos para las aplicaciones menos comunes de la lepirudina.
Videos de Conceptos Relacionados
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
613
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
613
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
749
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
01:30Inhibitors of Viral Protein Synthesis
58
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
58